- Busiest Month, Week and Day Ever for U.S. and European Cash and Derivatives Trading
- Cash Volumes: +110% in Europe and + 63% in the U.S. year-on-year
- Derivatives volumes: +75% in Europe and +103% in the U.S. year-on-year
Record transaction volumes on its U.S. and European cash equities and derivatives exchanges in August produced the busiest trading month ever for NYSE Euronext (NYX), the world's most liquid and most diversified global exchange group.
In August, NYSE Group handled(1) a record total of 3.6 billion shares for year-over-year gains of 62.8%. In Europe, more than 33 million transactions(2) were recorded on Euronext's four cash equities markets, up 110.5% year-over-year. The company's European derivatives markets traded a record 103.9 million contracts for the month, for gains of 75.0% year-over-year. In the U.S., NYSE Arca reported 1.4 million equity option contracts executed daily on average in August, up 103% year-over-year.
"In addition to record transaction volume in August, we also experienced record system activity and message traffic on our trading platforms, which performed exceptionally well," said Nelson Chai, Chief Financial and Executive Vice President, NYSE Euronext.
CASH PRODUCTS Euronext -- Volumes on Euronext's cash markets more than doubled in August, with 33.3 million transactions completed, up 110.5% from the same month last year, making the month the busiest ever. -- In total, more than 210 million cash transactions were registered on Euronext since the beginning of the year, up 42.9% from the same period in 2006. -- In August 2007, Euronext's cash markets broke several significant records with respect to trading activity, volume and systems capacity. Five new top ten volume days were registered during the month, with more than 2.4 million transactions completed on Aug. 17 - the busiest day ever for Euronext's markets. -- Euronext reported 31.9 million equities transactions in August 2007, up 112.0% from the same month last year, bringing the total number of equity transactions since January 2007 to 201 million, up 43.4% on the same period last year. -- Year-on-year transactions on Euronext were up 337.1% for ETFs and up 76.9% for Structured Products, which include warrants and certificates. Since the beginning of the year, transactions have improved 3.3% for Bonds. NYSE Group -- NYSE Group exchanges reported a record 3.6 billion shares handled per day in August, up 62.8% year-over-year and 17.1% year-to-date. -- During August, NYSE Group exchanges reached new all-time records in daily, weekly and monthly trading volumes. NYSE Group's U.S. cash equities trading operations reported a combined volume of over 22 billion shares traded during the week-ended Aug. 10, its highest ever. On Aug. 16, NYSE Group recorded its most active trading day ever in its U.S. cash equities trading operation with 5.39 billion shares changing hands. -- NYSE Group once again processed more transactions than any other U.S. exchange group with a total of 74.9 billion shares traded and 82.8 billion shares handled during the month. August's record trading volumes and message traffic highs produced the three most active weeks and seven of the top ten most active days in NYSE Group history. -- NYSE Group's operations in NYSE-listed securities reported 2.8 billion shares handled per day, up 68.7% from the same month last year and 21.1% year-to-date. -- As the largest liquidity pool for ETFs in the U.S., NYSE Group reported 453 million shares handled daily, up 204.5% from the same period last year and 58.4% year-to-date. DERIVATIVES PRODUCTS Liffe -- In what is usually the quietest month of the year, Liffe, NYSE Euronext's leading futures and options business, recorded its busiest month ever, trading a total of 104 million futures and options contracts, up 75% from August last year. This is the first time that Liffe has traded more than 100 million contracts in a single month. Over 628 million contracts have been traded year-to-date, up 26.4% from the same period last year. -- Interest rate products traded over 66 million contracts in August, up 79.6% from the same month last year. Of this total, 63 million contracts were in short-term interest rate (STIR) products - an all-time record month. Over 344 million contracts have been traded year-to-date, up 24.2% from the same period last year. -- Equity products traded over 36 million contracts in August, up 69.3% from the same month last year. More than 275 million equity products have been traded year-to-date, up 29.3% year-on-year. -- Liffe's pioneering Bclear service processed over 4 million contracts in August - more than double the number processed in August last year. 75 million contracts have been processed by Bclear during 2007 so far - up 99% year-on-year. -- In August, over 190,000 contracts were traded in the new early trading session in Euribor futures (01:00 - 07:00 hrs London time), up 8% on July. The longer trading day, which facilitates market access for customers in Asia and Australia, was launched on June 25. -- Liffe's commodity products traded 1.1 million futures and options contracts in August. Volumes are up 25.4% year-to-date. NYSE Arca Options -- NYSE Arca reported 1.37 million equity option contracts executed daily on average in August, up 103% from the same month last year, and up 9% from July 2007. -- From January 1 through August 31, 2007, NYSE Arca Options achieved a 58% increase in its share of trading in SEC penny pilot issues. -- NYSE Arca's average daily volume in the penny pilot issues has increased 168% to 294 thousand contracts per day in August, up from 110 thousand contracts per day in January 2007. -- NYSE Arca Options' third month of trading index options produced a total volume increase of over 24 thousand contracts traded, more than a 49% increase in volume from July 2007. LISTINGS Euronext -- Five IPOs were listed on Euronext's markets in August 2007, bringing the total number of IPOs since the beginning of the year to a record 101, as compared to 84 during the same period in 2006, with EUR 5.6/$7.7 billion raised in connection with new listings. -- Additionally, one new ETF was listed on NextTrack in August, bringing the total number of new ETF listings since the beginning of the year to 53. NYSE Group -- In August, there were 32 new listings on NYSE Group markets, including funds and structured products. Among the 12 new listings by operating companies were eight IPOs (excluding funds) that raised a total of EUR 2.5/$3.4 billion. -- The eight IPOs by operating companies included four non-US companies that raised a total of EUR 1.4/$1.9 billion in proceeds. -- There were also nine new ETF listings that joined NYSE Group markets in the month of August, as well as eleven structured products. Note:
Based on second-quarter 2007 non-GAAP combined revenues (excluding activity assessment fees, and liquidity payments, routing and clearing fees) NYSE Euronext revenues from its primary business activities are represented below as a percentage of total net revenues:
-- Derivatives trading accounts for 21% -- European cash trading accounts for 16% -- U.S. cash trading accounts for 10% -- Market data accounts for 14% -- Listing accounts for 13% On August 31, 2007: EUR 1 = $1.3641 Appendix: NYSE Euronext Markets Tables About NYSE Euronext
NYSE Euronext, a holding company created by the combination of NYSE Group, Inc. and Euronext N.V., commenced trading on April 4, 2007. NYSE Euronext (NYSE Euronext: NYX) operates the world's largest and most liquid exchange group and offers the most diverse array of financial products and services. NYSE Euronext, which brings together six cash equities exchanges in five countries and six derivatives exchanges in six countries, is a world leader for listings, trading in cash equities, equity and interest rate derivatives, bonds and the distribution of market data. Representing a combined $30.8 trillion/EUR 22.8 trillion total market capitalization of listed companies and average daily trading value of approximately $127.0 billion/EUR 94.0 billion (as of June 29, 2007), NYSE Euronext seeks to provide the highest standards of market quality and integrity, innovative products and services to investors, issuers, and all users of its markets.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2006 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on June 6, 2007 under No. R.07-0089), 2006 Annual Report on Form 10-K, as amended, and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
The following are trade marks of Euronext and may not be used without obtaining a license from Euronext: CAC(R), CAC 40(R), AEX(R), AEX-index(R), BEL 20(R), PSI 20(R), EURONEXT(R), LIFFE CONNECT(R), TRACKER(R).
FLEX(R) is a registered trademark of the Chicago Board Options Exchange Inc. and has been licensed for use by LIFFE.
(1) Handled shares represent the total number of shares of equity securities internally matched on the NYSE Group's exchanges or routed to and executed at an external market center.
(2) Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.
NYSE Euronext Monthly Volume Summary - Cash Products ---------------------------------------------------------------------- Average Daily Volume Total Volume -------------------- -------------------- (Unaudited) Aug-07 Aug-06 % Chg Aug-07 Aug-06 % Chg ------ ------ ------ ------ ------ ------ Number of Trading Days - European Markets 23 23 23 23 Number of Trading Days - U.S. Markets 23 23 23 23 European Cash Products (trades in thousands) 1,446 687 110.5% 33,253 15,796 110.5% Equities 1,388 655 112.0% 31,934 15,061 112.0% Exchange-Traded Funds 8 2 337.1% 176 40 337.1% Structured Products 45 26 76.9% 1,039 587 76.9% Bonds 5 5 -3.6% 104 108 -3.6% U.S. Cash Products (shares in millions) NYSE Listed Issues (1) NYSE Group Handled Volume (2) 2,796 1,657 68.7% 64,319 38,115 68.7% NYSE Group Matched Volume (3) 2,580 1,614 59.8% 59,347 37,128 59.8% NYSE Group TRF Volume (4) 79 - - 1,810 - - Total NYSE Listed Consolidated Volume 4,271 2,309 85.0% 98,223 53,097 85.0% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 65.5% 71.8% 65.5% 71.8% Matched Volume (3) 60.4% 69.9% 60.4% 69.9% TRF Volume (4) 1.8% - 1.8% - NYSE Arca & Amex Listed Issues NYSE Group Handled Volume (2) 341 110 209.8% 7,835 2,529 209.8% NYSE Group Matched Volume (3) 295 95 211.7% 6,796 2,181 211.7% NYSE Group TRF Volume (4) 39 - - 907 - - Total NYSE Arca & Amex Listed Consolidated Volume 874 290 200.9% 20,102 6,680 200.9% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 39.0% 37.9% 39.0% 37.9% Matched Volume (3) 33.8% 32.6% 33.8% 32.6% TRF Volume (4) 4.5% - 4.5% - Nasdaq Listed Issues NYSE Group Handled Volume (2) 463 444 4.3% 10,652 10,209 4.3% NYSE Group Matched Volume (3) 381 366 3.9% 8,755 8,425 3.9% NYSE Group TRF Volume (4) 163 - - 3,747 - - Total Nasdaq Listed Consolidated Volume 2,350 1,731 35.7% 54,047 39,816 35.7% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 19.7% 25.6% 19.7% 25.6% Matched Volume (3) 16.2% 21.2% 16.2% 21.2% TRF Volume (4) 6.9% - 6.9% - Exchange-Traded Funds (1,5) NYSE Group Handled Volume (2) 453 149 204.5% 10,408 3,418 204.5% NYSE Group Matched Volume (3) 403 133 202.8% 9,264 3,060 202.8% NYSE Group TRF Volume (4) 55 - - 1,273 - - Total ETF Consolidated Volume 1,086 341 218.5% 24,972 7,841 218.5% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 41.7% 43.6% 41.7% 43.6% Matched Volume (3) 37.1% 39.0% 37.1% 39.0% TRF Volume (4) 5.1% - 5.1% - Total Volume ------------------- % Chg vs. (Unaudited) YTD 2007 YTD 2006 --------- --------- Number of Trading Days - European Markets 171 Number of Trading Days - U.S. Markets 168 European Cash Products (trades in thousands) 210,293 42.9% Equities 201,305 43.4% Exchange-Traded Funds 972 118.6% Structured Products 6,870 32.4% Bonds 1,147 3.3% U.S. Cash Products (shares in millions) NYSE Listed Issues (1) NYSE Group Handled Volume (2) 381,093 21.1% NYSE Group Matched Volume (3) 355,891 15.4% NYSE Group TRF Volume (4) 3,949 - Total NYSE Listed Consolidated Volume 560,246 34.7% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 68.0% Matched Volume (3) 63.5% TRF Volume (4) - NYSE Arca & Amex Listed Issues NYSE Group Handled Volume (2) 34,192 60.6% NYSE Group Matched Volume (3) 29,600 60.4% NYSE Group TRF Volume (4) 2,041 - Total NYSE Arca & Amex Listed Consolidated Volume 89,288 46.3% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 38.3% Matched Volume (3) 33.2% TRF Volume (4) - Nasdaq Listed Issues NYSE Group Handled Volume (2) 77,163 -8.7% NYSE Group Matched Volume (3) 63,117 -8.6% NYSE Group TRF Volume (4) 13,168 - Total Nasdaq Listed Consolidated Volume 369,612 7.5% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 20.9% Matched Volume (3) 17.1% TRF Volume (4) - Exchange-Traded Funds (1,5) NYSE Group Handled Volume (2) 46,047 58.4% NYSE Group Matched Volume (3) 41,156 57.4% NYSE Group TRF Volume (4) - - Total ETF Consolidated Volume 107,389 58.6% NYSE Group Share of Total Consolidated Volume Handled Volume (2) 42.9% Matched Volume (3) 38.3% TRF Volume (4) -
NYSE Euronext ---------------------------------------------------------------------- Monthly Volume Summary - Derivatives Products ---------------------------------------------------------------------- Average Daily Volume Total Volume -------------------- ---------------------- (Unaudited; contracts in thousands) Aug-07 Aug-06 % Chg Aug-07 Aug-06 % Chg ------ ------ ------ ------- ------- ------ Number of Trading Days - European Markets 23 23 23 23 Number of Trading Days - U.S. Markets 23 23 23 23 European Derivatives Products 4,518 2,582 75.0% 103,920 59,380 75.0% Total Interest Rate Products 2,899 1,614 79.6% 66,671 37,112 79.6% Short Term Interest Rate Products 2,764 1,514 82.6% 63,562 34,819 82.6% Medium and Long Term Interest Rate Products 135 100 35.6% 3,109 2,293 35.6% Total Equity Products (6) 1,570 927 69.3% 36,104 21,324 69.3% Individual Equity Products 853 533 59.9% 19,611 12,268 59.9% Equity Index Products 717 394 82.1% 16,493 9,056 82.1% of which Bclear 194 95 105.2% 4,472 2,179 105.2% Individual Equity Products 128 66 93.9% 2,933 1,513 93.9% Equity Index Products 67 29 130.9% 1,539 667 130.9% Commodity Products 48 38 25.4% 1,100 878 25.4% Currency Products 2 3 -32.4% 45 66 -32.4% U.S. Derivatives Products - Equity Options (7) NYSE Arca Options Contracts 1,367 672 103.5% 31,440 15,453 103.5% Total Consolidated Options Contracts 11,370 6,325 79.8% 261,505 145,467 79.8% NYSE Group Share of Total 12.0% 10.6% 12.0% 10.6% Total Volume -------------------- % Chg vs. (Unaudited; contracts in thousands) YTD 2007 YTD 2006 --------- ---------- Number of Trading Days - European Markets 171 Number of Trading Days - U.S. Markets 168 European Derivatives Products 628,688 26.4% Total Interest Rate Products 344,872 24.2% Short Term Interest Rate Products 325,061 23.8% Medium and Long Term Interest Rate Products 19,811 29.5% Total Equity Products (6) 275,295 29.3% Individual Equity Products 172,163 30.4% Equity Index Products 103,133 27.3% of which Bclear 75,160 99.2% Individual Equity Products 63,002 119.2% Equity Index Products 12,159 35.3% Commodity Products 8,194 25.4% Currency Products 326 21.9% U.S. Derivatives Products - Equity Options (7) NYSE Arca Options Contracts 197,447 62.3% Total Consolidated Options Contracts 1,639,579 36.5% NYSE Group Share of Total 12.0% 1.9%
(1) Includes all volume executed in NYSE Group crossing sessions. (2) Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. (3) Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. (4) Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility (TRF). (5) Data included in previously identified categories. (6) Includes all trading activities for Bclear, Euronext.liffe's clearing service for wholesale equity derivatives. (7) Includes trading in U.S. equity options contracts, not equity- index options. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.